These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2407355)

  • 21. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University.
    Edwards NM; Rajasinghe HA; John R; Chen JM; Itescu S; Mancini DM
    Clin Transpl; 1999; ():249-61. PubMed ID: 11038644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune monitoring of blood in heart transplant recipients: application of flow cytometry.
    Garner RJ; Springgate C; Hoyt T
    Semin Diagn Pathol; 1989 Feb; 6(1):83-90. PubMed ID: 2645626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of right ventricular endomyocardial biopsy in the long-term management of heart-lung transplant recipients.
    Glanville AR; Imoto E; Baldwin JC; Billingham ME; Theodore J; Robin ED
    J Heart Transplant; 1987; 6(6):357-61. PubMed ID: 3121820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression.
    Renlund DG; Bristow MR; Crandall BG; Burton NA; Doty DB; Karwande SV; Gay WA; Jones KW; Hegewald MG; Hagan ME
    J Heart Transplant; 1989; 8(3):214-9; discussion 219-20. PubMed ID: 2661771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective use of OKT3 in heart transplantation with the use of risk factor analysis.
    Macris MP; Van Buren CT; Sweeney MS; Frazier OH; Duncan JM
    J Heart Transplant; 1989; 8(4):296-302. PubMed ID: 2504896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
    Valantine H; Zuckermann A
    J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S185-90; discussion S210-1. PubMed ID: 15774320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
    Valantine H
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S187-93. PubMed ID: 15093804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart and heart-lung transplantation.
    Muirhead J
    Nurs Clin North Am; 1989 Dec; 24(4):865-80. PubMed ID: 2685776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience.
    Costanzo-Nordin MR; O'Sullivan EJ; Hubbell EA; Zucker MJ; Pifarre R; McManus BM; Winters GL; Scanlon PJ; Robinson JA
    J Heart Transplant; 1989; 8(4):288-95. PubMed ID: 2504895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
    Zwirska-Korczala K; Zakliczyński M; Berdowska A; Zembala M; Jochem J; Gajewska K
    J Heart Lung Transplant; 2005 Apr; 24(4):411-5. PubMed ID: 15797741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
    Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
    J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
    [No Abstract]   [Full Text] [Related]  

  • 34. Heart-lung transplantation: an overview.
    Starnes VA
    Cardiol Clin; 1990 Feb; 8(1):159-68. PubMed ID: 2407357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of asymptomatic biliary tract disease in heart transplant recipients.
    Girardet RE; Rosenbloom P; DeWeese BM; Masri ZH; Attum AA; Barbie RN; Yared SF; Lusk RA; Lansing AM
    J Heart Transplant; 1989; 8(5):391-9. PubMed ID: 2795282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
    Roussel JC; Baron O; Périgaud C; Bizouarn P; Pattier S; Habash O; Mugniot A; Petit T; Michaud JL; Heymann MF; Treilhaud M; Trochu JN; Gueffet JP; Lamirault G; Duveau D; Despins P
    J Heart Lung Transplant; 2008 May; 27(5):486-93. PubMed ID: 18442713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
    Hirsch RL; Layton PC; Barnes LA; Kremer AB; Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
    [No Abstract]   [Full Text] [Related]  

  • 38. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
    Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
    J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arteriolar vasculitis on endomyocardial biopsy: a histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients.
    Herskowitz A; Soule LM; Ueda K; Tamura F; Baumgartner WA; Borkon AM; Reitz BA; Achuff SC; Traill TA; Baughman KL
    J Heart Transplant; 1987; 6(3):127-36. PubMed ID: 3309214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.